• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Differences in adherence to buccal epithelial cells, in phagocytosis and in killing by neutrophils between human and non-human strains of Candida albicans.

作者信息

Skoutelis A, Lianou P, Marselou O, Papavassiliou J, Bassaris H

机构信息

Department of Medicine, Patras University Medical School, Greece.

出版信息

J Infect. 1995 Jan;30(1):17-21. doi: 10.1016/s0163-4453(95)92717-4.

DOI:10.1016/s0163-4453(95)92717-4
PMID:7751660
Abstract

The adherence of strains of Candida albicans to buccal epithelial cells as well as the phagocytosis of these organisms by human polymorphonuclear leucocytes (PMNL) was studied. The strains of C. albicans were obtained from patients' urine. from bird faeces and from soil. The strains of C. albicans obtained from patients and the environment displayed greater adhering ability (23.8 +/- 6.4 and 27.5 +/- 5.2 respectively) than the avian strains (14.4 +/- 2.2) (P < 0.01). Strains obtained from the environment were resistant to phagocytosis (81.6 +/- 0.2 organisms ingested per 200 PMNL) and killing (8.4 +/- 2.6%) by PMNL as compared to human and avian strains (P < 0.01). These observations indicate that environmental strains of C. albicans may be more virulent for human beings.

摘要

相似文献

1
Differences in adherence to buccal epithelial cells, in phagocytosis and in killing by neutrophils between human and non-human strains of Candida albicans.
J Infect. 1995 Jan;30(1):17-21. doi: 10.1016/s0163-4453(95)92717-4.
2
Variability of the adherence of Candida albicans strains to human buccal epithelial cells: inconsistency of differences between strains related to virulence.白色念珠菌菌株对人颊上皮细胞黏附的变异性:与毒力相关的菌株间差异的不一致性。
Sabouraudia. 1983 Jun;21(2):93-8. doi: 10.1080/00362178385380161.
3
Interactions of Candida albicans yeast cells, germ tubes and hyphae with human polymorphonuclear leucocytes in vitro.白色念珠菌酵母细胞、芽管和菌丝体与人多形核白细胞在体外的相互作用。
J Gen Microbiol. 1984 Mar;130(3):465-71. doi: 10.1099/00221287-130-3-465.
4
Adherence of Candida albicans to human vaginal and buccal epithelial cells.白色念珠菌对人阴道和口腔上皮细胞的黏附
J Infect Dis. 1981 Jan;143(1):76-82. doi: 10.1093/infdis/143.1.76.
5
Candida albicans adherence to a human oesophageal cell line.白色念珠菌对人食管细胞系的黏附
Microbiology (Reading). 1996 Oct;142 ( Pt 10):2741-6. doi: 10.1099/13500872-142-10-2741.
6
[In vitro investigations of microphages function in patients with chronic mucocutaneous candidosis (author's transl)].慢性黏膜皮肤念珠菌病患者巨噬细胞功能的体外研究(作者译)
Immun Infekt. 1979 Feb;7(1):24-9.
7
Opsonic effect of C-reactive protein on phagocytosis and intracellular killing of virulent and attenuated strains of Candida albicans by human neutrophils.C反应蛋白对人中性粒细胞吞噬和细胞内杀灭白色念珠菌强毒株和减毒株的调理作用。
FEMS Microbiol Immunol. 1991 Nov;3(6):341-4. doi: 10.1111/j.1574-6968.1991.tb04259.x.
8
The possible influence of the menstrual cycle on the adherence of Candida albicans to human buccal epithelial cells in vitro.月经周期对白色念珠菌体外黏附人颊黏膜上皮细胞的潜在影响。
Arch Oral Biol. 1993 Apr;38(4):353-5. doi: 10.1016/0003-9969(93)90143-a.
9
Effective phagocytosis and killing of Candida albicans via targeting FcgammaRI (CD64) or FcalphaRI (CD89) on neutrophils.通过靶向中性粒细胞上的FcγRI(CD64)或FcαRI(CD89)有效吞噬和杀灭白色念珠菌。
J Infect Dis. 1999 Mar;179(3):661-9. doi: 10.1086/314643.
10
Candida albicans cellular internalization: a new pathogenic factor?白色念珠菌的细胞内吞作用:一种新的致病因素?
Int J Antimicrob Agents. 2000 Dec;16(4):545-7. doi: 10.1016/s0924-8579(00)00296-x.

引用本文的文献

1
Effects of conidia of various Aspergillus species on apoptosis of human pneumocytes and bronchial epithelial cells.不同曲霉菌种分生孢子对人肺细胞和支气管上皮细胞凋亡的影响。
Mycopathologia. 2009 May;167(5):249-62. doi: 10.1007/s11046-008-9175-3. Epub 2009 Jan 1.